Giacomo ChiesiHead of Global Rare Diseases at The Chiesi Group
Giacomo is currently Head of Global Rare Diseases at the Chiesi Group, where he leads the team developing and commercializing treatments for rare and ultra-rare diseases.
He was previously Head of Global Corporate Development at the Chiesi Group where he led the team through an intense deal making activity. The deals were instrumental for Chiesi to become a global company with expansion to a number of new countries including Canada, Australia and China,enter and grow its presence in the US market, selectively expand in the over-the-counter space in Europe and establish a global portfolio and pipeline in rare diseases, which culminated in the constitution of a new business unit: Global Rare Diseases.
In 2014, he founded Chiesi Ventures as a joint venture with Pappas Capital, an established life science venture capital fund, where he currently serves as Managing Partner. He serves as a Board Member on the Boards of the Chiesi Group and Chiesi USA. He was previously an observer or board member at Glycomine, Aura Biosciences, Sentien Biotech and Minoryx Therapeutics
Before joining the family business, Giacomo was a consultant with Bain & Co, where he led teams in a variety of assignments including due diligence, restructuring and strategy projects for consumer goods and IT companies in different countries. Previously he was with Accenture where he led large teams in outsourcing projects across Europe and US for clients in the transportation and retail business.
Giacomo earned a M.Sc. degree Magna cum Laude in Telecommunications Engineering from the University of Parma, Italy, and an MBA from the University of Chicago Booth School of Business with concentrations in Entrepreneurship and Finance. He practices calisthenics every day and enjoys spending time with his wife and kids, reading, traveling, and playing guitar